• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用 16S rDNA 和宏基因组测序技术分析回避/限制型食物摄入障碍儿童的粪便微生物组。

Using 16S rDNA and metagenomic sequencing technology to analyze the fecal microbiome of children with avoidant/restrictive food intake disorder.

机构信息

Department of Traditional Chinese Medicine, Guangzhou Women and Children Medical Center, No. 9 Jinsui Road, Guangzhou, 510623, China.

Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.

出版信息

Sci Rep. 2023 Nov 20;13(1):20253. doi: 10.1038/s41598-023-47760-y.

DOI:10.1038/s41598-023-47760-y
PMID:37985845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10661725/
Abstract

To investigate the gut microbiota distribution and its functions in children with avoidant/restrictive food intake disorder (ARFID). A total of 135 children were enrolled in the study, including 102 children with ARFID and 33 healthy children. Fecal samples were analyzed to explore differences in gut microbiota composition and diversity and functional differences between the ARFID and healthy control (HC) groups via 16S rDNA and metagenomic sequencing. The gut microbiota composition and diversity in children with ARFID were different from those in heathy children, but there is no difference in the composition and diversity of gut microbiota between children at the age of 3-6 and 7-12 with ARFID. At the phylum level, the most abundant microbes in the two groups identified by 16S rDNA and metagenomic sequencing were the same. At the genus level, the abundance of Bacteroides was higher in the ARFID group (P > 0.05); however, different from the result of 16SrDNA sequencing, metagenomic sequencing showed that the abundance of Bacteroides in the ARFID group was significantly higher than that in the HC group (P = 0.041). At the species level, Escherichia coli, Streptococcus thermophilus and Lachnospira eligens were the most abundant taxa in the ARFID group, and Prevotella copri, Bifidobacterium pseudocatenulatum, and Ruminococcus gnavus were the top three microbial taxa in the HC group; there were no statistically significant differences between the abundance of these microbial taxa in the two groups. LefSe analysis indicated a greater abundance of the order Enterobacterales and its corresponding family Enterobacteriaceae, the family Bacteroidaceae and corresponding genus Bacteroides, the species Bacteroides vulgatus in ARFID group, while the abundance of the phylum Actinobacteriota and its corresponding class Actinobacteria , the order Bifidobacteriales and corresponding family Bifidobacteriaceae, the genus Bifidobacterium were enriched in the HC group. There were no statistically significant differences in the Chao1, Shannon and Simpson indices between the Y1 and Y2 groups (P = 0.1, P = 0.06, P = 0.06). At the phylum level, Bacillota, Bacteroidota, Proteobacteria and Actinobacteriota were the most abundant taxa in both groups, but there were no statistically significant differences among the abundance of these bacteria (P = 0.958, P = 0.456, P = 0.473, P = 0.065). At the genus level, Faecalibacterium was more abundant in the Y2 group than in the Y1 group, and the difference was statistically significant (P = 0.037). The KEGG annotation results showed no significant difference in gut microbiota function between children with ARFID and healthy children; however, GT26 was significantly enriched in children with ARFID based on the CAZy database. The most abundant antibiotic resistance genes in the ARFID group were the vanT, tetQ, adeF, ermF genes, and the abundance of macrolide resistance genes in the ARFID group was significantly higher than that in the HC group (P = 0.041). Compared with healthy children, children with ARFID have a different distribution of the gut microbiota and functional genes. This indicates that the gut microbiome might play an important role in the pathogenesis of ARFID.Clinical trial registration: ChiCTR2300074759.

摘要

研究回避/限制型食物摄入障碍(ARFID)儿童的肠道微生物群分布及其功能。共纳入 135 名儿童,包括 102 名 ARFID 儿童和 33 名健康儿童。通过 16S rDNA 和宏基因组测序分析粪便样本,探索 ARFID 组和健康对照组(HC 组)之间肠道微生物群组成和多样性以及功能差异。ARFID 儿童的肠道微生物群组成和多样性与健康儿童不同,但 3-6 岁和 7-12 岁 ARFID 儿童的肠道微生物群组成和多样性无差异。在门水平上,16S rDNA 和宏基因组测序鉴定的两组中最丰富的微生物相同。在属水平上,ARFID 组中拟杆菌属的丰度较高(P>0.05);然而,与 16SrDNA 测序结果不同,宏基因组测序显示 ARFID 组中拟杆菌属的丰度明显高于 HC 组(P=0.041)。在种水平上,大肠杆菌、嗜热链球菌和lachnospira eligens 是 ARFID 组中最丰富的分类群,而 prevotella copri、双歧杆菌假链状、和 rumincoccus gnavus 是 HC 组中最丰富的三种微生物类群;两组之间这些微生物类群的丰度没有统计学差异。LefSe 分析表明,ARFID 组中肠杆菌目及其相应的肠杆菌科、拟杆菌科及其相应的拟杆菌属、普通拟杆菌的丰度较高,而 HC 组中放线菌门及其相应的放线菌纲、双歧杆菌目及其相应的双歧杆菌科、双歧杆菌属的丰度较高。Y1 和 Y2 组的 Chao1、Shannon 和 Simpson 指数无统计学差异(P=0.1、P=0.06、P=0.06)。在门水平上,芽孢杆菌、拟杆菌门、变形菌门和放线菌门是两组中最丰富的分类群,但这些细菌的丰度无统计学差异(P=0.958、P=0.456、P=0.473、P=0.065)。在属水平上,Y2 组中粪杆菌的丰度高于 Y1 组,差异有统计学意义(P=0.037)。KEGG 注释结果显示,ARFID 儿童和健康儿童的肠道微生物群功能无显著差异;然而,基于 CAZy 数据库,ARFID 儿童中 GT26 明显富集。ARFID 组中丰度最高的抗生素抗性基因是 vanT、tetQ、adeF、ermF 基因,ARFID 组中大环内酯类抗性基因的丰度明显高于 HC 组(P=0.041)。与健康儿童相比,ARFID 儿童的肠道微生物群分布和功能基因存在差异。这表明肠道微生物群可能在 ARFID 的发病机制中起重要作用。临床试验注册号:ChiCTR2300074759。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/aeda986c6de9/41598_2023_47760_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/c433031ce75a/41598_2023_47760_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/3a3062bdaa30/41598_2023_47760_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/2820bed05b5f/41598_2023_47760_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/9df4623e2bc6/41598_2023_47760_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/69b5882e41b3/41598_2023_47760_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/fd3bb5c342ad/41598_2023_47760_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/8eab4d892d4c/41598_2023_47760_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/5fe51423c600/41598_2023_47760_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/c3e9c455cd28/41598_2023_47760_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/abe2647f74f2/41598_2023_47760_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/5685c9189e73/41598_2023_47760_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/bba14cd38e22/41598_2023_47760_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/47c421281949/41598_2023_47760_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/63a9807b3340/41598_2023_47760_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/6ec8bd360af8/41598_2023_47760_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/7fb961a5a9ee/41598_2023_47760_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/aeda986c6de9/41598_2023_47760_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/c433031ce75a/41598_2023_47760_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/3a3062bdaa30/41598_2023_47760_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/2820bed05b5f/41598_2023_47760_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/9df4623e2bc6/41598_2023_47760_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/69b5882e41b3/41598_2023_47760_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/fd3bb5c342ad/41598_2023_47760_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/8eab4d892d4c/41598_2023_47760_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/5fe51423c600/41598_2023_47760_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/c3e9c455cd28/41598_2023_47760_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/abe2647f74f2/41598_2023_47760_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/5685c9189e73/41598_2023_47760_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/bba14cd38e22/41598_2023_47760_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/47c421281949/41598_2023_47760_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/63a9807b3340/41598_2023_47760_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/6ec8bd360af8/41598_2023_47760_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/7fb961a5a9ee/41598_2023_47760_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b1/10661725/aeda986c6de9/41598_2023_47760_Fig17_HTML.jpg

相似文献

1
Using 16S rDNA and metagenomic sequencing technology to analyze the fecal microbiome of children with avoidant/restrictive food intake disorder.采用 16S rDNA 和宏基因组测序技术分析回避/限制型食物摄入障碍儿童的粪便微生物组。
Sci Rep. 2023 Nov 20;13(1):20253. doi: 10.1038/s41598-023-47760-y.
2
[Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].[16S核糖体RNA高通量测序技术分析特重度烧伤患者肠道微生物群的动态变化]
Zhonghua Shao Shang Za Zhi. 2020 Dec 20;36(12):1159-1166. doi: 10.3760/cma.j.cn501120-20200518-00271.
3
Association between childhood obesity and gut microbiota: 16S rRNA gene sequencing-based cohort study.儿童肥胖与肠道微生物群的关联:基于 16S rRNA 基因测序的队列研究。
World J Gastroenterol. 2024 Apr 28;30(16):2249-2257. doi: 10.3748/wjg.v30.i16.2249.
4
Analysis of fecal microbiota and related clinical indicators in ICU patients with sepsis.脓毒症重症监护病房患者粪便微生物群及相关临床指标分析
Heliyon. 2024 Mar 27;10(7):e28480. doi: 10.1016/j.heliyon.2024.e28480. eCollection 2024 Apr 15.
5
[Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors].[初诊IgA肾病患者肠道菌群变化及其与临床危险因素的相关性]
Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Feb 18;55(1):124-132. doi: 10.19723/j.issn.1671-167X.2023.01.019.
6
A metagenomic study of the gut microbiome in PTB'S disease.肺结核患者肠道微生物群的宏基因组学研究。
Microbes Infect. 2022 Mar;24(2):104893. doi: 10.1016/j.micinf.2021.104893. Epub 2021 Oct 25.
7
Gut microbiota of one-and-a-half-year-old food-allergic and healthy children.一岁半食物过敏和健康儿童的肠道微生物群。
Allergol Int. 2024 Oct;73(4):550-555. doi: 10.1016/j.alit.2024.03.004. Epub 2024 Apr 9.
8
Features of gut microbiota in patients with anorexia nervosa.厌食症患者的肠道微生物群特征。
Chin Med J (Engl). 2022 Aug 20;135(16):1993-2002. doi: 10.1097/CM9.0000000000002362.
9
Association of gut microbiota with idiopathic membranous nephropathy.肠道微生物群与特发性膜性肾病的关联。
BMC Nephrol. 2022 Apr 30;23(1):164. doi: 10.1186/s12882-022-02797-5.
10
Characterization of the oral and gut microbiome in children with obesity aged 3 to 5 years.3 至 5 岁肥胖儿童口腔和肠道微生物组的特征。
Front Cell Infect Microbiol. 2023 Mar 29;13:1102650. doi: 10.3389/fcimb.2023.1102650. eCollection 2023.

引用本文的文献

1
Unraveling the Connections: Eating Issues, Microbiome, and Gastrointestinal Symptoms in Autism Spectrum Disorder.揭示关联:自闭症谱系障碍中的饮食问题、微生物群和胃肠道症状
Nutrients. 2025 Jan 29;17(3):486. doi: 10.3390/nu17030486.
2
A Role for the Microbiota-Gut-Brain Axis in Avoidant/Restrictive Food Intake Disorder: A New Conceptual Model.微生物群-肠-脑轴在回避/限制性食物摄入障碍中的作用:一种新的概念模型。
Int J Eat Disord. 2024 Dec;57(12):2321-2328. doi: 10.1002/eat.24326. Epub 2024 Nov 14.
3
Cytokine and Microbiome Changes in Adolescents with Anorexia Nervosa at Admission, Discharge, and One-Year Follow-Up.

本文引用的文献

1
Current evidence for avoidant restrictive food intake disorder: Implications for clinical practice and future directions.回避性限制性食物摄入障碍的当前证据:对临床实践的启示及未来方向
JCPP Adv. 2023 Apr 3;3(2):e12160. doi: 10.1002/jcv2.12160. eCollection 2023 Jun.
2
Faecalibacterium: a bacterial genus with promising human health applications.粪杆菌属:具有广阔人类健康应用前景的细菌属。
FEMS Microbiol Rev. 2023 Jul 5;47(4). doi: 10.1093/femsre/fuad039.
3
Survey of Clinical Practice Patterns of Korean Medicine Doctors for Anorexia in Children: A Preliminary Study for Clinical Practice Guidelines.
青少年神经性厌食症患者入院时、出院时和一年随访时的细胞因子和微生物组变化。
Nutrients. 2024 May 23;16(11):1596. doi: 10.3390/nu16111596.
韩国医学医生治疗儿童厌食症的临床实践模式调查:临床实践指南的初步研究
Children (Basel). 2022 Sep 17;9(9):1409. doi: 10.3390/children9091409.
4
Contribution of TagA-Like Glycosyltransferases to the Assembly of the Secondary Cell Wall Polysaccharide in Bacillus anthracis.炭疽杆菌次生细胞壁多糖组装中 TagA 样糖基转移酶的作用。
J Bacteriol. 2022 Sep 20;204(9):e0025322. doi: 10.1128/jb.00253-22. Epub 2022 Aug 23.
5
ARFID-Strategies for Dietary Management in Children.进食障碍-儿童饮食管理策略。
Nutrients. 2022 Apr 22;14(9):1739. doi: 10.3390/nu14091739.
6
Gut microbiome development and childhood undernutrition.肠道微生物组的发育与儿童营养不良。
Cell Host Microbe. 2022 May 11;30(5):617-626. doi: 10.1016/j.chom.2022.04.002.
7
The long-term genetic stability and individual specificity of the human gut microbiome.人类肠道微生物组的长期遗传稳定性和个体特异性。
Cell. 2021 Apr 29;184(9):2302-2315.e12. doi: 10.1016/j.cell.2021.03.024. Epub 2021 Apr 9.
8
Effects of Microbiota Imbalance in Anxiety and Eating Disorders: Probiotics as Novel Therapeutic Approaches.微生物群失衡在焦虑症和饮食失调中的影响:益生菌作为新型治疗方法
Int J Mol Sci. 2021 Feb 26;22(5):2351. doi: 10.3390/ijms22052351.
9
The Changing Face of the Family (Order: ""): New Members, Taxonomic Issues, Geographic Expansion, and New Diseases and Disease Syndromes.家庭的变化面貌(订单:" "):新成员、分类学问题、地理扩张以及新的疾病和疾病综合征。
Clin Microbiol Rev. 2021 Feb 24;34(2). doi: 10.1128/CMR.00174-20. Print 2021 Mar 17.
10
Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma.食管微生物群特征与食管鳞状细胞癌进展的关系
Chin J Cancer Res. 2020 Dec 31;32(6):755-767. doi: 10.21147/j.issn.1000-9604.2020.06.09.